Xiaogang Peng
6PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 06, 2025
The deubiquitylase OTUB1 drives gemcitabine resistance in pancreatic cancer by enhancing pyrimidine metabolism through modulating DHODH mRNA stability.Wenming Zhang, Rui Liu, Junwen Hu
|Sep 06, 2024
Identification of STAM-binding protein as a target for the treatment of gemcitabine resistance pancreatic cancer in a nutrient-poor microenvironment.Wenming Zhang, Zheng Xu, Yunyan Du
|May 16, 2024
E3 ubiquitin ligase UBR5 promotes gemcitabine resistance in pancreatic cancer by inducing O-GlcNAcylation-mediated EMT via destabilization of OGA.Yunyan Du, Zhangjian Yang, Hao Shi
|Sep 11, 2023
Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis.Ruowen Zhang, Xiaogang Peng, James Xianxing Du
|Sep 29, 2021
USP28 facilitates pancreatic cancer progression through activation of Wnt/β-catenin pathway via stabilising FOXM1.Leifeng Chen, Zheng Xu, Qing Li
|Oct 30, 2020
E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.Leifeng Chen, Rongfa Yuan, Chongyu Wen
Pageof 1
Frequent Collaborators
3 joint publications
Leifeng Chen
2 joint publications
Yunyan Du
1 joint publications
Yunyan Du
1 joint publications
Rongfa Yuan
1 joint publications
Ruowen Zhang
1 joint publications
James Xianxing Du
1 joint publications
Rebecca Boohaker
1 joint publications
Igor L Estevao
1 joint publications
Brian I Grajeda
1 joint publications
Marc B Cox
